Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
300 hedge funds and large institutions have $5.55B invested in Syneos Health, Inc. Class A Common Stock in 2020 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 119 increasing their positions, 97 reducing their positions, and 32 closing their positions.
118% more call options, than puts
Call options by funds: $5.17M | Put options by funds: $2.37M
53% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 32
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
23% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 97
5% more funds holding
Funds holding: 285 → 300 (+15)
10% less capital invested
Capital invested by funds: $6.15B → $5.55B (-$604M)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$106M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$41.2M |
| 3 |
CCM
CAAS Capital Management
New York
|
+$37.3M |
| 4 |
BTP
Bloom Tree Partners
New York
|
+$33.7M |
| 5 |
Goldman Sachs
New York
|
+$32.6M |
Top Sellers
SYNH Hedge Fund Activity: Q3 2020 in Review
300 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q3 2020, worth a combined $5.55B — down 9.8% from $6.15B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new SYNH positions and 32 closed out — a net gain of 17 holders — while 119 added to existing stakes and 97 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $106M. The largest seller was Advent International, cutting an estimated $224M.
- 300 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q3 2020, up from 285 in Q2 2020.
- Funds reported $5.55B of Syneos Health, Inc. Class A Common Stock stock for Q3 2020, down 9.8% quarter-over-quarter.
- 49 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q3 2020 and 32 closed out, a net change of +17 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q3 2020 was Fidelity Investments, an estimated $106M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q3 2020 was Advent International, an estimated $224M sold.
Based on aggregated 13F filings for Q3 2020.